Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma

Glypican-3 (GPC3) has been reported to be a novel serum and histochemical marker for HCC. The positivity or negativity for GPC3 in hepatic precancerous lesions, such as dysplastic nodules (DN), has also been described. Moreover, our previous studies have demonstrated that some DN in liver cirrhosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Li, Wei, Long-Xiao, Ren, Pin, Zhang, Wen-Dong, Liu, Xiao-Yan, Han, Xiu-Juan, Yao, Li, Zhu, Shao-Jun, Lan, Miao, Li, Yan-Hong, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909016/
https://www.ncbi.nlm.nih.gov/pubmed/24498024
http://dx.doi.org/10.1371/journal.pone.0087120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909016/
https://www.ncbi.nlm.nih.gov/pubmed/24498024
http://dx.doi.org/10.1371/journal.pone.0087120

Ejemplares similares